Clinica 100: The rise and rise of Mindray
This article was originally published in Clinica
China's success may have been founded in mass manufacturing of commodity products, but the country now boasts some home-grown companies which are churning out notable innovations in their respective fields. Mindray Medical is one such concern that has been increasingly attracting the attention of its international peers. The firm's vice-president of international marketing Richard Yang talks to Tina Tan about what has been helping the company grow from strength to strength and how it is staving off competitors who have their sights on Mindray's home turf
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.